Symrise has announced a strategic equity investment in US-based biotechnology company Bond Pet Foods, deepening its push into fermentation-derived, animal-identical proteins for pet nutrition. 

 

The move is aimed at expanding Symrise’s pet food portfolio with biotech-enabled ingredients designed to improve performance for pets while reducing environmental impact.

 

The partnership centers on Bond Pet Foods’ precision fermentation platform, which produces animal-identical proteins and is expected to help address persistent industry pressures such as supply-chain stability and rising demand for more sustainable pet food ingredients. 

 

For manufacturers, the collaboration is intended to widen access to high-quality protein alternatives while supporting more resilient and responsible sourcing models.

 

“This investment marks an important step in advancing our strategy to develop next-generation sustainable ingredients with biotechnology. 

 

"By combining Bond’s fermentation capabilities with Symrise’s application expertise and market insight, we can deliver high-performance nutrition solutions and create new growth opportunities for our customers,” said Diego Maurizio, General Manager, Palatability & Nutrition Business Line at Symrise.

 

Founded in 2017, Bond Pet Foods has been building its precision fermentation platform to produce animal-identical proteins for pet nutrition, advancing through multiple development agreements aimed at commercial application in the pet food sector.

 

“We have put great effort into building a new way to produce animal-identical proteins for pet food applications. Now, we find it exciting to see that work gaining traction across the industry", said Rich Kelleman, CEO of Bond Pet Foods. 

 

"Partnering with Symrise marks an important step forward bringing their deep expertise in pet nutrition and taste to further expand how our ingredients perform and can be used by pet food manufacturers."

 

Symrise says the investment also reflects its broader strategy to scale biotechnology across its business and strengthen long-term innovation.

 

"This investment advances our ambition to scale biotechnology across our business. With this, we aim at effectively supporting long-term resilience, portfolio diversification, and a stronger innovation pipeline", says Walter Ribeiro, President Taste, Nutrition & Health at Symrise. 

 

"By helping our customers develop more sustainable pet food formulations, the collaboration reinforces Symrise’s sustainability commitments and consumer-driven innovation strategy."